← All trials
NCT01720667
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2013
- Primary completion
- Jul 1, 2017
- Completion date
- Jul 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of California, San DiegoLead sponsor
- University of California, San DiegoOverall official - principal investigator
- University of California, San DiegoSponsor investigator
- University of California, San DiegoCollaborator
- Sharp Mary Birch Hospital for Women & Newborns, San Diego, CACollaborator
- University of AucklandCollaborator
- University of California, San FranciscoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.